-transparent.png){kind=logo}
Biopsy specimens were obtained from patients treated with N-(phosphonacetyl)-L-aspartate (PALA) in a phase I clinical trial. Activities of aspartate carbamoyltransferase (ACTase), the target enzyme, in ten specimens before treatment varied from 0.4 to 1.7 units/mg. PALA was measured in protein-free extracts of thirteen specimens by inhibition of rat ACTase. At 1.5 to 145 hr after doses of 1 to 6 g/m2, PALA concentrations were 0.9 to 89 micrograms/g; at 4 hr or later the tissue concentrations were similar to those in plasma (five samples). The observed inhibition of ACTase (17-87%) correlated with the PALA concentrations. Pyrimidine nucleotides were decreased (relative to purine nucleotides) in nine to ten specimens, by 16-72%. ACTase partially purified from human spleen had a Km for carbamoyl phosphate of 20.6 microM and the Ki for PALA was 0.011 microM. The results suggest that inhibition of ACTase by PALA affects the concentration of pyrimidine nucleotides in human tumors in a dose-dependent manner.
E C Moore, and
J Friedman, and
M Valdivieso, and
W Plunkett, and
J R Marti, and
J Russ, and
T L Loo
April 1986,
Biochemical and biophysical research communications,
E C Moore, and
J Friedman, and
M Valdivieso, and
W Plunkett, and
J R Marti, and
J Russ, and
T L Loo
February 1987,
Journal of molecular biology,
E C Moore, and
J Friedman, and
M Valdivieso, and
W Plunkett, and
J R Marti, and
J Russ, and
T L Loo
January 1993,
Advances in experimental medicine and biology,
E C Moore, and
J Friedman, and
M Valdivieso, and
W Plunkett, and
J R Marti, and
J Russ, and
T L Loo
March 1985,
Proceedings of the National Academy of Sciences of the United States of America,
E C Moore, and
J Friedman, and
M Valdivieso, and
W Plunkett, and
J R Marti, and
J Russ, and
T L Loo
October 1982,
Biochemical pharmacology,
E C Moore, and
J Friedman, and
M Valdivieso, and
W Plunkett, and
J R Marti, and
J Russ, and
T L Loo
November 1974,
The Journal of biological chemistry,
E C Moore, and
J Friedman, and
M Valdivieso, and
W Plunkett, and
J R Marti, and
J Russ, and
T L Loo
December 1988,
Journal of molecular biology,
E C Moore, and
J Friedman, and
M Valdivieso, and
W Plunkett, and
J R Marti, and
J Russ, and
T L Loo
January 1984,
Journal of the American Academy of Dermatology,
E C Moore, and
J Friedman, and
M Valdivieso, and
W Plunkett, and
J R Marti, and
J Russ, and
T L Loo
July 1992,
Annals of internal medicine,
E C Moore, and
J Friedman, and
M Valdivieso, and
W Plunkett, and
J R Marti, and
J Russ, and
T L Loo
November 1981,
European journal of cancer & clinical oncology,
